Exchanges
BSE, NSE
Industry
Hospital
Issue
Book building

Global Health IPO

₹415.30

+23.60% on listing

Listing-day close · NSE · 16 Nov 2022 · issue price ₹336

Global Health’s ₹2,206 crore IPO was priced at ₹336 a share. It listed on the NSE on 16 Nov 2022 and closed its first day at ₹415.30, up 23.60% on the issue price.

Timeline

  1. Opens
  2. Closes
  3. Allotment
  4. Refunds
  5. Shares in demat
  6. Listing

Issue details

Issue size
₹2,206 Cr
Fresh issue
₹500 Cr
Offer for sale
₹1,706 Cr
Lot size
44 shares
Minimum investment
₹14,784
Face value
₹2
Registrar
Kfin Technologies

Subscription

Global Health IPO subscription by investor category
CategoryShares offeredTimes subscribed
Total—7.11×

Overall, from the basis of allotment.

Financials and valuation

Market cap (post-issue)
₹9,011 Cr
P/E (post-issue)
38.4
EPS (post-issue)
₹8.76
Price to book
5.3
ROE
13.10%
ROCE
16.30%
Debt to equity
0.50
EBITDA margin
21.92%
PAT margin
9.00%
Promoter holding
35.00% → 33.00%

Financials as of 31 Mar 2022, from the offer documents.

Listing

Listing date
16 Nov 2022
Issue price
₹336
Open
₹401.00
High
₹424.65
Low
₹390.55
Close
₹415.30

Listing day on the NSE. The close was +23.60% on the issue price.

FAQs

When did the Global Health IPO open and close?

It opened on 3 Nov 2022 and closed on 7 Nov 2022.

What was the Global Health IPO price?

The price band was ₹319–336 a share. The final issue price was ₹336.

What is the lot size and minimum investment?

One lot is 44 shares, ₹14,784 at ₹336 a share. Retail investors apply in whole lots.

How much did Global Health raise?

₹2,206 crore: ₹500 crore of new shares and ₹1,706 crore offered by existing shareholders.

How many times was the Global Health IPO subscribed?

7.11 times overall.

How did Global Health list?

It listed on the NSE on 16 Nov 2022 at ₹401.00 and closed the day at ₹415.30, up 23.60% on the ₹336 issue price.

Who is the registrar of the Global Health IPO?

Kfin Technologies handles the allotment, refunds and credit of shares.

For information only. Not investment advice or a research report.

Full disclaimer

See how an IPO fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app